Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
glioblastoma
high grade glioma, anaplastic astrocytoma, anaplastic oligodendroglioma, glioblastoma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 967436
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.